We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
XTRA:UP0
​
​
logo

Ultragenyx Pharmaceutical Inc. (UP0)

XTRA • UP0 • US90400D1081

15.17Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 4.4% of free float is sold short, cost to borrow 0.42%.

Market Cap

1.69b USD | # 4260 in DE

Volume

52 shares | 4.03k USD

Shares Outstanding

98.29m

Free Float Shares

75.39% | 74.1m

Nasdaq:RARE|
DB:UP0|
LSE:0LIF|
BOVESPA:R2AR34

News

UP0 key data

Ultragenyx Pharmaceutical Inc. (XTRA: UP0) has a market capitalization of $1.69B. Last close €15.17 (as of 2026-11-05); 52-week range €13.00 to €15.43. ORTEX data as of 2026-11-03: short interest is 4.43% of free float and the average cost to borrow is 0.42%.

  • UP0 news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.